These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2192850)

  • 21. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
    Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Possibilities and limits of oral diabetes therapy].
    Bruneder H
    Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin in the early management of diabetic complications.
    Miles JM
    J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of NIDDM with insulin agonists or substitutes.
    Galloway JA
    Diabetes Care; 1990 Dec; 13(12):1209-39. PubMed ID: 1980453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin plus a sulfonylurea agent for treating type 2 diabetes.
    Peters AL; Davidson MB
    Ann Intern Med; 1991 Jul; 115(1):45-53. PubMed ID: 1828656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale for the association of sulfonylurea and insulin.
    Del Prato S
    Am J Med; 1991 Jun; 90(6A):77S-82S. PubMed ID: 1872309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of insulin therapy on body fat distribution in NIDDM patients with secondary sulfonylurea failure: a preliminary report.
    Takei I; Takayama S; Yamauchi A; Nakamoto S; Kitamura Y; Katsukawa F; Yamazaki H; Saruta T; Inoue S
    Eur J Clin Nutr; 1998 Feb; 52(2):153-4. PubMed ID: 9505163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
    Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
    Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus.
    Gibson JM; Westwood M; Crosby SR; Gordon C; Holly JM; Fraser W; Anderson C; White A; Young RJ
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1369-75. PubMed ID: 7536208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined insulin and sulfonylurea therapy in non-insulin-dependent diabetics with secondary failure to oral drugs: a one year follow-up.
    Quatraro A; Consoli G; Ceriello A; Giugliano D
    Diabete Metab; 1986 Dec; 12(6):315-8. PubMed ID: 3545931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined insulin and sulfonylurea therapy for type 2 diabetes mellitus.
    Riddle MC
    Diabetes Res Clin Pract; 1991 Jan; 11(1):3-8. PubMed ID: 2019232
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination oral agent and insulin therapy for type 2 diabetes mellitus.
    Passaro MD; Ratner RE
    Curr Diab Rep; 2001 Oct; 1(2):106-11. PubMed ID: 12643105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.
    Marrero DG
    Clin Cornerstone; 2007; 8(2):33-40; discussion 41-3. PubMed ID: 18357954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic sensitivity to insulin: effects of sulfonylurea drugs.
    Del Prato S; Vigili de Kreutzenberg S; Riccio A; Tiengo A
    Am J Med; 1991 Jun; 90(6A):29S-36S. PubMed ID: 1872301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes care: what should we try to achieve?
    O'Connor PJ
    J Fam Pract; 1991 Oct; 33(4):343-4. PubMed ID: 1919448
    [No Abstract]   [Full Text] [Related]  

  • 36. The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.
    Kolterman OG; Gray RS; Shapiro G; Scarlett JA; Griffin J; Olefsky JM
    Diabetes; 1984 Apr; 33(4):346-54. PubMed ID: 6423429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.
    Sonnenberg GE; Garg DC; Weidler DJ; Dixon RM; Jaber LA; Bowen AJ; DeChemey GS; Mullican WS; Stonesifer LD
    Ann Pharmacother; 1997 Jun; 31(6):671-6. PubMed ID: 9184703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfonylureas.
    Zimmerman BR
    Endocrinol Metab Clin North Am; 1997 Sep; 26(3):511-22. PubMed ID: 9314012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes.
    Min JY; Griffin MR; Hung AM; Grijalva CG; Greevy RA; Liu X; Elasy T; Roumie CL
    J Gen Intern Med; 2016 Jun; 31(6):638-46. PubMed ID: 26921160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
    Bressler R; Johnson DG
    Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.